Salvus Wealth Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $259K | Buy |
3,270
+119
| +4% | +$9.42K | 0.15% | 107 |
|
|
2025
Q1 | $283K | Sell |
3,151
-9,386
| -75% | -$843K | 0.18% | 102 |
|
|
2024
Q4 | $1.25M | Sell |
12,537
-2,888
| -19% | -$287K | 0.8% | 33 |
|
|
2024
Q3 | $1.75M | Buy |
15,425
+61
| +0.4% | +$6.93K | 1.08% | 30 |
|
|
2024
Q2 | $1.9M | Buy |
15,364
+96
| +0.6% | +$11.9K | 1.31% | 22 |
|
|
2024
Q1 | $2.01M | Buy |
15,268
+61
| +0.4% | +$8.05K | 1.38% | 20 |
|
|
2023
Q4 | $1.66M | Sell |
15,207
-50
| -0.3% | -$5.45K | 1.18% | 24 |
|
|
2023
Q3 | $1.57M | Buy |
15,257
+366
| +2% | +$37.7K | 1.24% | 23 |
|
|
2023
Q2 | $1.72M | Buy |
14,891
+230
| +2% | +$26.5K | 1.32% | 21 |
|
|
2023
Q1 | $1.56M | Buy |
14,661
+143
| +1% | +$15.2K | 1.26% | 22 |
|
|
2022
Q4 | $1.61M | Sell |
14,518
-64
| -0.4% | -$7.1K | 1.48% | 22 |
|
|
2022
Q3 | $1.26M | Buy |
14,582
+380
| +3% | +$32.7K | 1.2% | 24 |
|
|
2022
Q2 | $1.3M | Sell |
14,202
-162
| -1% | -$14.8K | 1.16% | 24 |
|
|
2022
Q1 | $1.18M | Buy |
14,364
+5,937
| +70% | +$487K | 0.9% | 31 |
|
|
2021
Q4 | $646K | Buy |
8,427
+219
| +3% | +$16.8K | 0.47% | 51 |
|
|
2021
Q3 | $617K | Buy |
8,208
+442
| +6% | +$33.2K | 0.5% | 46 |
|
|
2021
Q2 | $606K | Buy |
7,766
+549
| +8% | +$42.8K | 0.51% | 45 |
|
|
2021
Q1 | $520K | Buy |
7,217
+611
| +9% | +$44K | 0.49% | 50 |
|
|
2020
Q4 | $523K | Buy |
+6,606
| New | +$523K | 0.57% | 43 |
|